Profile | GDS4284 / 202396_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 6649.73 | 95 |
GSM687648 | Patient 402 control | 6658.4 | 95 |
GSM687653 | Patient 403 control | 7708.26 | 96 |
GSM687658 | Patient 404 control | 5894.65 | 94 |
GSM687663 | Patient 411 control | 6292.03 | 95 |
GSM687668 | Patient 422 control | 7247.12 | 96 |
GSM687673 | Patient 424 control | 5200.27 | 94 |
GSM687678 | Patient 425 control | 4931.4 | 93 |
GSM687683 | Patient 427 control | 5583.18 | 94 |
GSM687688 | Patient 428 control | 5589.45 | 94 |
GSM687695 | Patient 441 control | 3342.01 | 91 |
GSM687699 | Patient 443 control | 4594.6 | 93 |
GSM687704 | Patient 444 control | 5956.93 | 94 |
GSM687707 | Patient 448 control | 7091.05 | 96 |
GSM687712 | Patient 449 control | 5954.8 | 94 |
GSM687719 | Patient 450 control | 5337.56 | 94 |
GSM687724 | Patient 451 control | 7135.84 | 96 |
GSM687728 | Patient 452 control | 6031.4 | 95 |
GSM687646 | Patient 401 treated 24h | 6846.02 | 95 |
GSM687649 | Patient 402 treated 24h | 7911.3 | 96 |
GSM687665 | Patient 411 treated 24h | 7017.93 | 96 |
GSM687651 | Patient 402 treated 4 weeks | 6078.05 | 95 |
GSM687667 | Patient 411 treated 4 weeks | 7536.29 | 96 |
GSM687670 | Patient 422 treated 24h | 6944.11 | 96 |
GSM687671 | Patient 422 treated 4 weeks | 7092.95 | 96 |
GSM687654 | Patient 403 treated 24h | 7339.8 | 96 |
GSM687675 | Patient 424 treated 24h | 5254.12 | 94 |
GSM687685 | Patient 427 treated 24h | 4998.68 | 93 |
GSM687656 | Patient 403 treated 4 weeks | 7304.71 | 96 |
GSM687677 | Patient 424 treated 4 weeks | 4917.44 | 93 |
GSM687687 | Patient 427 treated 4 weeks | 6826.58 | 95 |
GSM687692 | Patient 428 treated 4h | 6598.02 | 95 |
GSM687716 | Patient 449 treated 4h | 5884.53 | 94 |
GSM687722 | Patient 450 treated 4h | 6112.95 | 95 |
GSM687680 | Patient 425 treated 24h | 6085.41 | 95 |
GSM687690 | Patient 428 treated 24h | 7885.42 | 96 |
GSM687700 | Patient 443 treated 24h | 3790.07 | 92 |
GSM687705 | Patient 444 treated 24h | 5878.27 | 94 |
GSM687714 | Patient 449 treated 24h | 6550.91 | 95 |
GSM687721 | Patient 450 treated 24h | 5099.97 | 94 |
GSM687682 | Patient 425 treated 4 weeks | 5033.96 | 93 |
GSM687694 | Patient 428 treated 4 weeks | 5662.29 | 94 |
GSM687702 | Patient 443 treated 4 weeks | 4201.5 | 92 |
GSM687718 | Patient 449 treated 4 weeks | 5050.11 | 93 |
GSM687723 | Patient 450 treated 4 weeks | 5607.18 | 94 |
GSM687661 | Patient 404 treated 4h | 6546.73 | 95 |
GSM687710 | Patient 448 treated 4h | 7187.97 | 95 |
GSM687726 | Patient 451 treated 4h | 6544.23 | 95 |
GSM687730 | Patient 452 treated 4h | 3584.99 | 92 |
GSM687660 | Patient 404 treated 24h | 4711.85 | 93 |
GSM687697 | Patient 441 treated 24h | 3331.9 | 90 |
GSM687709 | Patient 448 treated 24h | 6722.17 | 95 |
GSM687725 | Patient 451 treated 24h | 7283.29 | 96 |
GSM687729 | Patient 452 treated 24h | 3544.17 | 91 |
GSM687727 | Patient 451 treated 4 weeks | 6416.75 | 95 |
GSM687731 | Patient 452 treated 4 weeks | 5435.04 | 94 |